VKTX01: A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients. IMAGINE (Interleukin 6 Blockade Modifying Antibody-Mediated Graft INjury a

Project: Research project

Project Details

StatusActive
Effective start/end date10/7/19 → 10/17/25

Funding

  • ICON Clinical Research, LLC (Prot#VKTX01 // Prot#VKTX01)
  • CSL Behring (Prot#VKTX01 // Prot#VKTX01)